Revenues

3 Months Ended

Mar. 31, 2022

Revenue from Contract with Customer [Abstract]

Revenues

Revenues

The following tables present revenue disaggregated by primary geographic market where the products are sold, by product line and timing of revenue recognition:

	Three Months Ended						Three Months Ended
	March 31, 2022						March 31, 2021
	Orthopedic Surgery		General Surgery		Total		Orthopedic Surgery		General Surgery		Total
Primary Geographic Markets
United States	$	37,947	$	93,280	$	131,227	$	37,131	$	86,812	$	123,943
Europe, Middle East & Africa	29,980		20,326		50,306		26,052		18,544		44,596
Asia Pacific	23,418		12,954		36,372		26,602		12,662		39,264
Americas (excluding the United States)	16,172		8,250		24,422		17,381		7,493		24,874
Total sales from contracts with customers	$	107,517	$	134,810	$	242,327	$	107,166	$	125,511	$	232,677
Timing of Revenue Recognition
Goods transferred at a point in time	$	98,204	$	133,322	$	231,526	$	97,690	$	124,394	$	222,084
Services transferred over time	9,313		1,488		10,801		9,476		1,117		10,593
Total sales from contracts with customers	$	107,517	$	134,810	$	242,327	$	107,166	$	125,511	$	232,677

Contract liability balances related to the sale of extended warranties to customers are as follows:

	March 31, 2022		December 31, 2021
Contract liability	$	17,534	$	16,760

Revenue recognized during the three months ended March 31, 2022 and March 31, 2021 from amounts included in contract liabilities at the beginning of the period were $3.9 million and $3.4 million, respectively. There were no material contract assets as of March 31, 2022 and December 31, 2021.